Transport Coefficients for Holographic Hydrodynamics at Finite Energy Scale

We investigate the relations between black hole thermodynamics and holographic transport coefficients in this paper. The formulae for DC conductivity and diffusion coefficient are verified for electrically single-charged black holes. We examine the correctness of the proposed expressions by taking charged dilatonic and single-charged STU black holes as two concrete examples, and compute the flows of conductivity and diffusion coefficient by solving the linear order perturbation equations. We then check the consistence by evaluating the Brown-York tensor at a finite radial position. Finally, we find that the retarded Green functions for the shear modes can be expressed easily in terms of black hole thermodynamic quantities and transport coefficients.Comment: 33 pages,4 figures,to appear in Advances in High Energy Physic

NMDA receptor internalization down-regulates NMDA receptor-mediated synaptic responses through the inhibition of remaining (non-internalized) surface NMDA receptors

Cell-surface protein endocytosis is critically involved in the regulation of organismal homeostasis, immune responses, development and neurotransmission [1,2,3,4]. Mechanisms underlying the endocytosis of cell surface proteins have been extensively investigated. However, until very recently no study has reported how non-internalized cell surface proteins may behave following endocytosis of same type of proteins. Here, we highlight findings that regulated NMDA receptor (NMDAR) internalization not only reduces the amount of NMDARs expressed on neuronal surface but also through activating PKD1 pathway phosphorylates and down-regulates remaining (non-internalized) surface NMDARs. This down-regulation of remaining surface NMDARs plays a critical role in the modulation of NMDAR-mediated synaptic responses by NMDAR internalization

Preparation and biological application of antibodies against leucoanthocyanidin reductase and anthocyanidin reductase from grape berry

Proanthocyanidins (PAs) endow wine with the flavor of bitterness and astringency. Both leucoanthocyanidin reductase (LAR) and anthocyanidin reductase (ANR) are two key enzymes of PA biosynthesis in grape berries, but the previous studies on these enzymes only focused on the transcriptional expression of these genes. Here, the full-length cDNAs of VvLAR1, VvLAR2 and VvANR, respectively, were cloned from wine grape berries and were then introduced into the pGEX-4T-1 expression vectors, which were highly expressed in Escherichia coli DH5α cells with the induction of the isopropyl-β-D-thiogalactoside (IPTG). The purified fusion proteins were used as the antigens to immunize rabbits, separately. The obtained antiserums were further purified to obtain the immunoglobulin G (Ig G) fractions, which were demonstrated to be capable of specifically immuno-recognizing the VvLAR1, VvLAR2 and VvANR from the crude protein extracts from grape berries with weight masses of approximately 43 kD. The analyses of translational expression of these enzyme genes during berry development and immunohistochemical localization of these proteins, by using the obtained antibodies, showed that a high amount of VvLAR1, VvLAR2 or VvANR was present at the pre-veraison stage and these enzyme proteins were all localized on the outer layer of the berry skin and the vascular bundle, as well as in the inner layer of the seed coat. This work provides an important basis for further studies on PA biosynthesis in grape berries.

(2,9-Dieth­oxy-1,10-phenanthroline-κ2 N,N′)bis­(thio­cyanato-κN)cobalt(II)

In the title complex, [Co(NCS)2(C16H16N2O2)], the CoII ion is coordinated by two N atoms from one 2,9-dieth­oxy-1,10-phenanthroline ligand and two N atoms from two different thio­cyanate ligands in a distorted tetra­hedral environment. The Co—N bonds involving the thio­cyanate ligands are significantly shorter than the other two Co—N bonds. The atoms of one of the eth­oxy groups are essentially coplanar with the phenanthroline ring [N=C—O—C = 178.8 (4)°], while the other eth­oxy group is slightly twisted from the phenanthroline ring plane [N=C—O—C = 167.2 (4)°]. In the crystal structure, there is a weak π–π stacking inter­action between two symmetry-related phenanthroline rings with a centroid–centroid distance of 3.706 (4) Å

The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome

Background: Our study&#8217;s aim was to evaluate the prognostic value of early and intensive lipid-lowering treatment on ventricular premature beat or non-sustained ventricular tachycardia (NSVT) after acute coronary syndrome (STEMI, non-STEMI, and unstable angina pectoris). Methods: Some 586 patients with acute coronary syndrome were randomly divided into two groups: Group A (with conventional statin therapy, to receive 10 mg/day atorvastatin, n = 289) and Group B (given early and intensive statin therapy, 60 mg immediately and 40 mg/day atorvastatin, n = 297). The frequency of ventricular premature beat and NSVT was recorded via Holter monitoring after hospitalization (24 h and 72 h). Results: Seventy seven (11.8%) patients had NSVT. When compared to patients with no documented NSVT, patients with NSVT were older and more frequently had myocardial infarction in their history, diabetes mellitus, atrial fibrillation and an ejection fraction < 40%. Ventricular premature beats decreased significantly in the early and aggressive treatment group (24 h, p < 0.01; 72 h, p < 0.001). A significant reduction in NSVT was seen in the early and aggressive treatment group (24 h, p < 0.01; 72 h, p < 0.001). There were no side effects observed in either group. Conclusions: Early and intensive lipid-lowering treatment can clearly decrease ventricular premature beats and NSVT. (Cardiol J 2010; 17, 4: 381-385

MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer

Background We recently reported that miR-1 was one of the most significantly downregulated microRNAs in gastric cancer (GC) patients from The Cancer Genome Atlas microRNA sequencing data. Here we aim to elucidate the role of miR-1 in gastric carcinogenesis. Methods We measured miR-1 expression in human GC cell lines and 90 paired primary GC samples, and analyzed the association of its status with clinicopathological features. The effect of miR-1 on GC cells was evaluated by proliferation and migration assay. To identify the target genes of miR-1, bioinformatic analysis and protein array analysis were performed. Moreover, the regulation mechanism of miR-1 with regard to these predicted targets was investigated by quantitative PCR (qPCR), Western blot, ELISA, and endothelial cell tube formation. The putative binding site of miR-1 on target genes was assessed by a reporter assay. Results Expression of miR-1 was obviously decreased in GC cell lines and primary tissues. Patients with low miR-1 expression had significantly shorter overall survival compared with those with high miR-1 expression (P = 0.0027). Overexpression of miR-1 in GC cells inhibited proliferation, migration, and tube formation of endothelial cells by suppressing expression of vascular endothelial growth factor A (VEGF-A) and endothelin 1 (EDN1). Conversely, inhibition of miR-1 with use of antago-miR-1 caused an increase in expression of VEGF-A and EDN1 in nonmalignant GC cells or low-malignancy GC cells. Conclusions MiR-1 acts as a tumor suppressor by inhibiting angiogenesis-related growth factors in human gastric cancer. Downregulated miR-1 not only promotes cellular proliferation and migration of GC cells, but may activates proangiogenesis signaling and stimulates the proliferation and migration of endothelial cells, indicating the possibility of new strategies for GC therapy

Model dostosowywania dawki i analiza czynnika współzależnego u chińskich pacjentów z cukrzycą typu 2 leczonych podstawową dawką insuliny — wyniki badania ORBIT (Observational Registry of Basal Insulin Treatment)

Introduction: This study evaluates an insulin dose titration model and factors that impact insulin dose adjustment in Chinese adults with type-2 diabetes, who receive basal insulin in real-world settings. Material and methods: A total of 19,894 patients from the ORBIT study were included. These patients were divided into four groups, according to the type of insulin dose adjustment: no insulin titration (group A), self-titration (group B), physician-led insulin titration (group C), and combined physician and patient-led insulin titration (group D). Data were collected and compared at baseline and after six months of treatment. Results: A total of 12,865 patients completed the visits and were included in the analysis. Among these patients, 3187 (24.8%), 1971 (15.3%), 5165 (40.1%), and 2542 (19.8%) patients were included in groups A, B, C, and D, respectively. The multivariate logistic regression analysis revealed that the duration of diabetes, body mass index, microvascular complications, inpatient days, HbA1C level, and self-monitoring of blood glucose (SMBG) were positively correlated with insulin titration in group B, C, and D, compared with group A. The number of inpatient days and outpatient visits were positively correlated with dose adjustment for physician-led titration, while this was negatively correlated for self-titration. Self-titration encouraged by physicians and home blood glucose monitoring were positively correlated with self-titration and the combined physician and patient-led titration. Conclusions: High HbA1C level, SMBG, long disease duration, microvascular complications, and the encouragement of physicians while initiating insulin use prompt patients to perform dose adjustments in real-world settings.Wstęp: Badanie ma na celu ocenę modelu dostosowywania dawki insuliny i czynników, mających wpływ na dostosowanie dawki insuliny u chińskich dorosłych pacjentów z cukrzycą typu 2 leczonych podstawową dawką insuliny w warunkach rzeczywistych. Materiał i metody: W badaniu udział wzięło 19 894 pacjentów z badania ORBIT, którzy zostali podzieleni na 4 grupy, w zależności od typu dostosowywania dawki insuliny: brak dostosowywania dawki insuliny (grupa A), samodzielne dostosowywanie dawki (grupa B), dostosowywanie dawki przez lekarza (grupa C) oraz dostosowywanie dawki zarówno przez lekarza jak i przez pacjenta (grupa D). Dane zostały zebrane i porównane na początku badania i po 6 miesiącach leczenia. Wyniki: Łącznie 12 865 pacjentów ukończyło wizyty i zostało uwzględnionych w analizie. Spośród tych pacjentów, 3187 (24,8%), 1971 (15,3%), 5165 (40,1%) i 2542 (19,8%) badanych włączono odpowiednio do grup A, B, C i D. Wieloczynnikowa analiza regresji logistycznej wykazała, że czas trwania cukrzycy, wskaźnik masy ciała, powikłania mikronaczyniowe, dni hospitalizacji, stężenie HbA1C i samokontrola stężenia glukozy we krwi (self-monitoring of blood glucose; SMBG) były dodatnio skorelowane z dostosowywaniem insuliny w grupach B, C i D w porównaniu z grupą A. Liczba dni hospitalizacji i wizyt ambulatoryjnych były dodatnio skorelowane z dostosowywaniem dawek przez lekarza i ujemnie skorelowane z samodzielnym dostosowywaniem dawki. Zachęcanie przez lekarzy do samodzielnego do­stosowywania dawki i monitorowanie stężenia glukozy we krwi w warunkach domowych były dodatnio skorelowane z samodzielnym dostosowywaniem dawki oraz dostosowywaniem dawki zarówno przez lekarza, jak i przez pacjenta. Wnioski: Wysokie stężenie HbA1C, samokontrola stężenia glukozy we krwi, długi czas trwania choroby, powikłania mikronaczyniowe oraz zachęta lekarzy podczas inicjowania podawania insuliny skłaniają pacjentów do dostosowywania dawek w warunkach rzeczywistych